BBOT

NASD BridgeBio Oncology Therapeutics, Inc.
Oct 29, 2026 · 8:07 AM ET LAST TRADE Market Closed

$2.80 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.80

YTD change
-77.64%
vs 20-day SMA
-9.49%
vs 200-day SMA
-65.96%

Price ranges

Previous day
$2.61 $2.86
open $2.67 close $2.80
+$0.13 (+4.87%)
Today
$0.00 $0.00
$2.80
Past week
$2.51 $2.86
from $2.68 now $2.80
+$0.12 (+4.48%)
Past month
$2.51 $4.10
from $4.10 now $2.80
-$1.30 (-31.71%)
This year
$2.51 $14.60
from $12.52 now $2.80
-$9.72 (-77.64%)

Price & Performance

-5.26 (-65.26%) / 6M

$2.08$4.77$7.47$10.16Apr 29Jul 30Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 81.2% away from all-time highs of $14.87
  • BBOT is down 78% since the beginning of the year
  • BBOT is down 76% over the past 12 months
  • BBOT is down 32% over the past 1 month
  • 5% of all BBOT investors are betting against BBOT

BBOT reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -75.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.705199
Earnings momentum -2.2% Quarterly EPS growth
Quarterly change -2.2%

Valuation

P/E ratio N/A
Enterprise value $-222973000.0
Beta 0.63

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$225.7M
Debt$2.5K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $224.3M

Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.